TikTok can be a valuable tool for promoting cervical cancer screening
TikTok and other short-form video platforms are booming in popularity -; for entertainment and for sharing information, including health information.
Community-wide health care initiative launched to reduce breast cancer disparities in the Houston area
The University of Texas MD Anderson Cancer Center today announced the launch of Texas Health Equity Alliance for Breast Cancer (THEAL), a community-wide health care initiative to reduce breast cancer…
New animal model replicates the development of cardiac sarcoidosis
Sarcoidosis is an inflammatory disease in which immune cells form tissue nodules in various organs, which can drastically impair organ function.
Study highlights racial and ethnic disparities in disability among older adults
Roughly 40% of older Black adults live with a disability, compared to only one-third of older adults overall.
Dads should be screened for postpartum depression, study suggests
Dads can suffer from postpartum depression, and a new pilot study at the University of Illinois Chicago suggests they can and should be screened for the condition.
USC-led team develops vaccine to boost immune system against superbugs
What if a vaccine, given to patients just before or after arriving at the hospital, could protect them against lethal superbugs that lurk in healthcare settings?
Heart attack care lags as hospitals recover from the pandemic
A door-to-balloon (D2B) time of 90-minutes or less is associated with improved outcomes for heart attack patients.
Why are most Americans skipping the COVID-19 booster?
A study in the journal Vaccine reveals that misinformation and concerns about side effects are leading reasons why over 80% of eligible Americans have skipped the SARS-CoV-2 vaccine booster. The…
How is TikTok’s #Ozempic trend impacting diabetes patients?
A recent study analyzed TikTok videos with the hashtag "Ozempic," highlighting the platform's influence on promoting the weight loss drug. The surge in popularity resulted in medication shortages for diabetes…
GLP-1 weight loss drugs linked to heightened GI risks, says new study
Study from JAMA reveals that users of GLP-1 agonists, recent drugs for weight management, show a heightened risk of gastrointestinal complications like intestinal obstruction, gastroparesis, and pancreatitis. Though these effects…